Endotoxin-induced inhibition of growth hormone receptor signaling in rat liver in vivo

Endocrinology

Volumn 140, Issue 12, 1999, Pages 5505-5515

  Mao, Yilei ^a   Ling, Pei Ra ^a   Fitzgibbons, Timothy P ^a   McCowen, Karen C ^a   Frick, G Peter ^b   Bistrian, Bruce R ^a   Smith, Robert J ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; CYTOKINE; ENDOTOXIN; GROWTH HORMONE; GROWTH HORMONE RECEPTOR; JANUS KINASE; MESSENGER RNA; STAT5 PROTEIN;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; GENE INDUCTION; HORMONAL REGULATION; HORMONE INHIBITION; HORMONE RESISTANCE; LIVER; MALE; MULTIGENE FAMILY; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

ESCHERICHIA COLI;

EID: 0033305487     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.140.12.7212     Document Type: Article

References (49)

1. Acquired growth hormone resistance
2. Mediators, hormones, and control of metabolism: Regulation of protein, carbohydrate, and lipid metabolism in critical illness
3. Neuroendocrine defence in endotoxin shock
4. Growth hormone treatment prevents the decrease in insulin-like growth factor I gene expression in patients undergoing abdominal surgery
5. Autocrine/paracrine insulin-like growth factor-I supports normal growth in the face of Cre/loxP targeted deletion of the hepatic igf1 gene
6. Insulin-like growth factor I production is inhibited in human sepsis
7. Critically ill patients have high basal growth hormone levels with attenuated oscillatory activity associated with low levels of insulin-like growth factor-I
8. Growth factors and wound healing
9. Increased mortality associated with growth hormone treatment in critically ill adults
10. Molecular mechanism of growth hormone action
11. Regulation of rat growth hormone receptor gene expression
12. Growth hormone stimulates tyrosine phosphorylation of JAK2 and STAT5, but not insulin receptor substrate-1 or SHC proteins in liver and skeletal muscle of normal rats in vivo
13. Mechanism of signaling by growth hormone receptor
14. Intermittent plasma growth hormone triggers tyrosine phosphorylation and nuclear translocation of a liver-expressed, Stat 5-related DNA binding protein. Proposed role as an intracellular regulator of male-specific liver gene transcription
15. Activation of acute phase response factor (APRF)/Stat3 transcription factor by growth hormone
16. Growth hormone stimulates tyrosine phosphorylation of insulin receptor substrate-1
17. Growth hormone and prolactin stimulate tyrosine phosphorylation of insulin receptor substrate-1, -2, and -3, their association with p85 phosphatidylinositol 3-kinase (PI3-kinase), and concomitantly PI3- kinase activation via JAK2 kinase
18. Growth hormone-promoted tyrosyl phosphorylation of SHC proteins and SHC association with Grb2
19. Nutritional regulation of the growth hormone and insulin-like growth factor-binding proteins
20. Measurement of human growth hormone receptor messenger ribonucleic acid by a quantitative polymerase chain reaction-based assay: Demonstration of reduced expression after elective surgery
21. Proinflammatory cytokines interleukin-1β and tumor necrosis factor-α inhibit growth hormone stimulation of insulin-like growth factor I synthesis and growth hormone receptor mRNA levels in cultured rat liver cells
22. Mechanisms of insulin resistance in human obesity: Evidence for receptor and postreceptor defects
23. Cellular alterations in liver, skeletal muscle, and adipose tissue responsible for insulin resistance in obesity and type II diabetes
24. Endotoxin-induced alterations in insulin-stimulated phosphorylation of insulin receptor,IRS-1, and MAP kinase in skeletal muscle
25. Acute alterations in growth hormone-insulin-like growth factor axis in humans injected with endotoxin
26. Differential role of glucocorticoids in mediating endotoxin-induced changes in IGF-I and IGFBP-1
27. Differential effects of endotoxin on plasma levels of glucose, insulin, IGF-I and corticosterone with or without nutrition support
28. The SOCS proteins: A new family of negative regulators of signal transduction
29. A family of cytokine-inducible inhibitors of signalling
30. Twenty proteins containing a C-terminal SOCS box form five structural classes
31. A novel cytokine-inducible gene CIS encodes an SH2-containing protein that binds to tyrosine-phosphorylated interleukin 3 and erythropoietin receptors
32. A new protein containing an SH2 domain that inhibits JAK kinases
33. Cloning and characterization of novel CIS family genes
34. Structure and function of a new STAT-induced STAT inhibitor
35. Growth hormone preferentially induces the rapid, transient expression of SOCS-3, a novel inhibitor of cytokine receptor signaling
36. Identification of SOCS-3 as a potential mediator of central leptin resistance
37. Changes in tyrosine phosphorylation of insulin receptors and a 170,000 molecular weight nonreceptor protein in vivo in skeletal muscle of streptozotocin-induced diabetic rats: Effects of insulin and glucose
38. Tissue distribution, turnover, and glycosylation of the long and short growth hormone receptor isoforms in rat tissues
39. Growth hormone stimulates the tyrosine kinase activity of JAK2 and induces tyrosine phosphorylation of insulin receptor substrates and Shc in rat tissues
40. Insulin stimulation of phosphatidylinositol 3-kinase activity and association with insulin receptor substrate 1 in liver and muscle of the intact rat
41. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
42. Cloning of the gene encoding rat JAK2, a protein tyrosine kinase
43. Cytokine signaling: Cytokine-inducible signaling inhibitors
44. Activation of Jak2 catalytic activity requires phosphorylation of Y1007 in the kinase activation loop
45. Cloning and characterization of the human homolog of mouse Jak2
46. Inhibition by interleukin-1β and tumor necrosis factor-α of the insulin-like growth factor I messenger ribonucleic acid response to growth hormone in rat hepatocyte primary culture
47. GH insensitivity induced by endotoxin injection is associated with decreased liver GH receptors
48. Specificity spillover at the hormone receptor-exploring its role in human disease
49. Plasma prolactin in acromegaly before and after treatment